Clearside Biomedical (CLSD) announced the appointment of Tony Gibney as Chair of its Board of Directors, effective November 1, 2024. Gibney, who joined Clearside’s Board as an independent director in April 2024, succeeds Clay Thorp, who will continue serving as a member of the Board.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLSD:
- Clearside Biomedical announces multiple presentations delivered at 2024 AAO
- Largest borrow rate increases among liquid names
- Clearside Biomedical management to meet with JMP Securities
- Biotech Alert: Searches spiking for these stocks today
- Stifel bullish on Clearside Biomedical as CLS-AX meets goals in Phase 2b ODYSSEY